藥物成份

共有 21387 個藥物成份

Epinephrine contains not less than 97.0% and not more than 100.5% of C9H13NO3, calculated on the dried basis.

關聯藥證數量
1

Epinephrine contains not less than 99.0% and not more than 101.0% of C9H13NO3，calculated on the dried substance.

關聯藥證數量
1

Epinephrine(3 x 0.5 ml), Collagen(calf skin)(3 x 0.5 ml), ADP(3 x 0.5 ml), Arachidonic Acid(3 x 0.5 ml)

關聯藥證數量
1

Epinephrine, 3 x 0.5 ml

關聯藥證數量
1

Epirubicin Hydrochloride contains not less than 97.0 % and not more than 102.0% of C27H30ClNO11, calculated on the anhydrous and solvent-free basis.

關聯藥證數量
1

Epirubicin Hydrochloride contains not less than 97.0% and not more than 102.0% of C27H30ClNO11, calculated on the anhydrous substance.

關聯藥證數量
1

Epirubicin Hydrochloride contains not less than 98.0% and not more than 102.0% on the anhydrous and solvent-free basis.

關聯藥證數量
1

Epoprostenol Sodium 95.0 ~ 105.0% (Dried basis) (最終含量範圍)

關聯藥證數量
1

Eprazinone HCl contains not less than 98.5% of C24H32N2O2∙2HCl calculated on dried substance.

關聯藥證數量
1

Eprazinone Hydrochloride contains not less than 98.5% of C24H32N2O2.2HCl (dried substances)

關聯藥證數量
1

Eprazinone Hydrochloride contains not less than 98.5% of C24H32N2O2‧2HCl calculated on the dried basis.

關聯藥證數量
1

Epstein-Barr Virus Coated Wells (IgA): 12 breakapart 8-well snap-off strips coated with Epstein-Barr Virus antigen; vacuum sealed, in resealable aluminium foil.\nIgA Sample Diluent ***: 1 bottle containing 100 ml of buffer for sample dilution; pH 7.2 ± 0.2; coloured yellow; ready to use; white cap. \nStop Solution: 1 bottle containing 15 ml sulphuric acid, 0.2 mol/l; ready to use; red cap.\nWashing Solution (20x conc.)*: 1 bottle containing 50 ml of a 20-fold concentrated buffer (pH 7.2 ± 0.2) for washing the wells; white cap.\nEpstein-Barr Virus anti-IgA Conjugate**: 1 bottle containing 20 ml of peroxidase labelled rabbit antibody to human IgA; coloured red, ready to use; black cap.\nTMB Substrate Solution: 1 bottle containing 15 ml 3,3,5,5-tetramethylbenzidine (TMB); ready to use; yellow cap.\nEpstein-Barr Virus IgA Positive Control***: 1 bottle containing 2 ml; coloured yellow; ready to use; red cap.\nEpstein-Barr Virus IgA Cut-off Control***: 1 bottle containing 2 ml; coloured yellow; ready to use; green

關聯藥證數量
1

Epstein-Barr Virus Coated Wells (IgG): 12 breakapart 8-well snap-off strips coated with Epstein-Barr Virus antigen; vacuum sealed, in resealable aluminium foil.\nIgG Sample Diluent ***: 1 bottle containing 100 ml of buffer for sample dilution; pH 7.2 ± 0.2; coloured yellow; ready to use; white cap. \nStop Solution: 1 bottle containing 15 ml sulphuric acid, 0.2 mol/l; ready to use; red cap.\nWashing Solution (20x conc.)*: 1 bottle containing 50 ml of a 20-fold concentrated buffer (pH 7.2 ± 0.2) for washing the wells; white cap.\nEpstein-Barr Virus anti-IgG Conjugate**: 1 bottle containing 20 ml of peroxidase labelled rabbit antibody to human IgG; coloured red, ready to use; black cap.\nTMB Substrate Solution: 1 bottle containing 15 ml 3,3,5,5-tetramethylbenzidine (TMB); ready to use; yellow cap.\nEpstein-Barr Virus IgG Positive Control***: 1 bottle containing 2 ml; coloured yellow; ready to use; red cap.\nEpstein-Barr Virus IgG Cut-off Control***: 1 bottle containing 2 ml; coloured yellow; ready to use; green

關聯藥證數量
1

Epstein-Barr Virus Coated Wells (IgG): 12 breakapart 8-well snap-off strips coated with recombinant Epstein-Barr Virus nuclear antigen EBNA-1; vacuum sealed, in resealable aluminium foil.\n

關聯藥證數量
1

Epstein-Barr Virus Coated Wells (IgM): 12 breakapart 8-well snap-off strips coated with Epstein-Barr Virus antigen; vacuum sealed, in resealable aluminium foil.\nIgM Sample Diluent ***: 1 bottle containing 100 ml of buffer for sample dilution; pH 7.2 ± 0.2; coloured yellow; ready to use; white cap. \nStop Solution: 1 bottle containing 15 ml sulphuric acid, 0.2 mol/l; ready to use; red cap.\nWashing Solution (20x conc.)*: 1 bottle containing 50 ml of a 20-fold concentrated buffer (pH 7.2 ± 0.2) for washing the wells; white cap.\nEpstein-Barr Virus anti-IgM Conjugate**: 1 bottle containing 20 ml of peroxidase labelled rabbit antibody to human IgG; coloured red, ready to use; black cap.\n

關聯藥證數量
1

Ergometrine Maleate contains not less than 98.0% and not more than 101.0% of C19H23N3O2‧C4H4O4, calculated on the dried basis.

關聯藥證數量
1

Ergometrine maleate contains not less than 98.0% and not more than 101.0% calculated on dried substance.

關聯藥證數量
1

Ergotamine Tartrate NLT 98.0% and NMT 101.0% of C70H76N10O16, calculated on the dried basis.

關聯藥證數量
1

Ergotamine tartrate contains not less than 98.0% and not more than 101.0% calculated on dried substance.

關聯藥證數量
1

Eribulin Mesylate contains 97.0%~103.0% (anhydrous and solvent free basis)

關聯藥證數量
1

Eribulin mesylate

關聯藥證數量
1

Erlotinib Hydrochloride (Form B) contains not less than 98.0 % and not more than 102.0 % of C22H24ClN3O4, calculated on the dried basis.

關聯藥證數量
1

Erlotinib Hydrochloride contains not less than 98.0% and not more than 102.0% of C22H24ClN3O4, calculated on the dried basis.

關聯藥證數量
1

Erlotinib hydrochloride (Form B) contains not less than 98.0 percent and not more than 102.0 percent of C22H23N3O4•HCl, calculated on the anhydrous.

關聯藥證數量
1

Ertapenem sodium contains not less than 96.0 percent calculated on the dry basis.

關聯藥證數量
1

Erythromycin 15ug/disk

關聯藥證數量
1

Erythromycin Estolate (Anhydrous basis) 86.0~102.0% Erythromycin B (Anhydrous basis) 5% (max) Erythromycin C (Anhydrous basis) 5% (max)

關聯藥證數量
1

Erythromycin Estolate has a potency equivalent to not less than 600 μg of erythromycin (C37H67NO13) per mg, calculated on the anhydrous basis.

關聯藥證數量
1

Erythromycin Estolate has a potency wquivalent to not less than 600 ug of erythromycin (C37H67NO13) per mg, calculated on the anhydrous basis.

關聯藥證數量
1

Erythromycin estolate contains not less than 600 μg of erythromycin (C37H67NO13) per mg, calculated on the anhydrous basis.

關聯藥證數量
1

Escin free acid contains not less than 95.0% of C55H86O24, calculated with reference to the anhydrous and solvent-free substance.

關聯藥證數量
1

Escitalopram Oxalate contains not less than 98.0% and not more than 101.0% of C20H21FN2O‧C2H2O4 calculated on the dried basis.

關聯藥證數量
1

Escitalopram Oxalate contains not less than 98.0% and not more than 102.0% of C20H21FN2O.C2H2O4, calculated on the anhydrous basis.

關聯藥證數量
1

Escitalopram Oxalate contains not less than 98.0% and not more than 102.0% of C20H21FN2O‧C2H2O4, calculated on the anhydrous basis.

關聯藥證數量
1

Escitalopram Oxalate contains not less than 98.0% and not more than 102.0% of escitalopram oxalate (C20H21FN2O．C2H2O4), calculated on the anhydrous basis.

關聯藥證數量
1

Escitalopram Oxalate contains not less than 99.0% and not more than 101.0% of C22H23FN2O5, calculated on the anhydrous basis.

關聯藥證數量
1

Escitalopram oxalate contains NLT 98.0% and NMT 102.0% of C20H21FN2O‧C2H2O4, calculated on the anhydrous basis.

關聯藥證數量
1

Escitalopram oxalate contains not less than 98.0% and not more than 102.0% of C20H21FN2O‧C2H2O4, calculated on the anhydrous basis.

關聯藥證數量
1

Esculin (e. q. Esculoside) contains 98%~100.5% of C15H16O9, 1.5 H2O (dried basis.)

關聯藥證數量
1

Esketamine HCl

關聯藥證數量
1

Esomeprazole Magnesium Dihydrate contains not less than 98.0% w/w and not more than 102.0% w/w, calculated on anhydrous basis.

關聯藥證數量
1

Esomeprazole Magnesium Trihydrate contains not less than 98.0% and not more than 102.0% of C34H36MgN6O6S2．3H2O, calculated on the anhydrous substance.

關聯藥證數量
1

Esomeprazole Magnesium Trihydrate contains not less than 98.0% and not more than 102.0% of C34H36MgN6O6S2‧3H2O, calculated on dried substance.

關聯藥證數量
1

Esomeprazole Magnesium trihydrate Content: 98.0 percent to 102.0 percent (anhydrous substance).

關聯藥證數量
1

Esomeprazole Sodium contains not less than 98.0% and not more than 102.0% of C17H18N3NaO3S，calculated on the dried basis.

關聯藥證數量
1

Estazolam contains NLT 98.0% and NMT 102.0% of C16H11ClN4, calculated on the dried basis.

關聯藥證數量
1

Estradiol Ab-Coated Tubes (TE21)：Polypropylene tubes coated with rebbit antibodies to estradiol.\n125I Estradiol (TE22)：Iodinated synthetic estradiol in liquid.\nEstradiol Calibrators (TE23-9)：0, 20, 50, 150, 500, 1800 and 3600 picograms of synthetic estradiol per millilter in processed human serum.

關聯藥證數量
1

Estradiol Benzoate contains not less than 97.0 percent and not more than 103.0 percent of C25H28O3, calculated on the dried basis.

關聯藥證數量
1

Estradiol II reagent\nM Streptavidin-coated microparticles 6.5 ml\nR1 Anti-estradiol-Ab~biotin 8 ml\nR2 Estradiol-peptide~Ru (bpy)2+3 8 ml\n\nEstradiol II CalSet\n2 bottles, each for 1.0 mL of calibrator 1\n2 bottles, each for 1.0 mL of calibrator 2\n\n

關聯藥證數量
1

Estradiol Valerate contains not less than 98.0% and not more than 102.0% of C23H32O3.

關聯藥證數量
1

Estradiol contains not less than 97% and not more than 103% of C18H24O2,calculated on the dried basis.

關聯藥證數量
1

Estriol (micronized) 97.5%~102.0%, C18H24O3

關聯藥證數量
1

Estriol contains not less than 97.0% and not more than 103.0% of C18H24O3, calculated on the dried substance.

關聯藥證數量
1

Eszopiclone contains not less than 99.0% and not more than 100.5% of C17H17ClN6O3 calculated on the dried basis.

關聯藥證數量
1

Eszopiclone contains not less than 99.0% and not more than 100.5% of C17H17ClN6O3, calculated on the dried basis.

關聯藥證數量
1

Etelcalcetide Hydrochloride

關聯藥證數量
1

Ethambutol Hydrochloride Assay (on dry basis)：99.0-101.0%

關聯藥證數量
1

Ethanol 96%, contains: ethanol 95.1% V/V (92.6% m/m) to 96.9% V/V (95.2% m/m) at 20°C, calculated from relative density using the alcoholmetric tables. Water

關聯藥證數量
1

Ethanol L3K® Reagent: a solution containing a buffer (pH 7.3 at 25°C), 1.35 mmol/L NAD analog , > 203 KU/L alcohol dehydrogenase (yeast), stabilizers, and a preservative.\n\nEthanol Standard: 1x5mL of a solution containing 20 mmol/L (92 mg/dL) ethanol and a preservative. \n

關聯藥證數量
1

Ethanolamine (pH 10.6) 0.375 mol/l\n8-Hydroxyquinoline 7.16 mmol/l\no-Cresolphthalein complexone 82.0 μmol/l\n

關聯藥證數量
1

Ethanolamine 1 mol/L\nGEDTA,xylidyl blue.\nStandard 2 mg/dl.

關聯藥證數量
1

Ethinyl Estradiol contains not less than 97.5% and not more than 102.0% of C20H24O2, calculated on the dried basis.

關聯藥證數量
1

Ethinyl estradiol contains not less than 97.5% and not more than 102.0% of C20H24O2 calculated on the dried basis.

關聯藥證數量
1

Ethinylestradiol contains not less than 97.0% and not more than 102.0% of C20H24O2, calculated on the dried basis.

關聯藥證數量
1

Ethinylestradiol contains not less than 97.5% and not more than 102.0% of C20H24O2, calculated on the dried substance.

關聯藥證數量
1

Ethyl Icosapentate contains not less than 96.5 percent of C22H34O2

關聯藥證數量
1

Ethylenediamine, ethoxylated and propoxylated

關聯藥證數量
1

Ethylhydrocuprein hydrochloride 5ug/disc

關聯藥證數量
1

Ethylphenylephrine HCl

關聯藥證數量
1

Etodolac contains 98.0% and not more than 102.0% of C17H21NO3 (anhydrous substance).

關聯藥證數量
1

Etodolac contains not less than 98.0 percent and not more than 102.0 percent of C17H21NO3, calculated on the anhydrous basis.

關聯藥證數量
1

Etodolac contains not less than 98.0 percent and not more than 102.0 percent of C17H21NO3, calculated on the anhydrous substance.

關聯藥證數量
1

Etodolac contains not less than 98.0% and not more than 102.0% of C17H21NO3, calculated on anhydrous substance.

關聯藥證數量
1

Etodolac contains not less than 98.0% and not more than 102.0% of C17H21NO3, calculated on the anhydrous basis.

關聯藥證數量
1

Etodolac contains not less than 98.0% and not more than 102.0% of C17H21NO3, calculated on the anhydrous substance.

關聯藥證數量
1

Etofenamate contains not less than 98.5% and not more than 101.5% of C18H18F3NO4, calculated on the anhydrous basis.

關聯藥證數量
1

Etofenamate content not less than 98.5% and not more than 101.5% of C18H18F3NO4, calculated on the dried basis.

關聯藥證數量
1

Etoricoxib contains NLT 98.0% and NMT 102.0% of Etoricoxib (C18H15ClN2O2S) per mg, calculated on the anhydrous basis.

關聯藥證數量
1

Etoricoxib contains NLT 98.0% and not NMT 102.0% of C18H15ClN2O2S, calculated on the anhydrous substance.

關聯藥證數量
1

Etoricoxib contains not less than 98.0 % and not more than 102.0 % of C18H15ClN2O2S, calculated on the anhydrous basis.

關聯藥證數量
1

Etoricoxib contains not less than 98.0% and not more than 102% of C18H15ClN2O2S, calculated on anhydrous basis.

關聯藥證數量
1

Etranacogene dezaparvovec

關聯藥證數量
1

Evaporation Caps 2CRP Reagent Bar Code Card 1REAGENT CARTRIDGE CONSTITUENTSCRP Antibody (particle bound polyclonal anti-C- 7.5mLreactive protein antibody;goat)

關聯藥證數量
1

Everolimus B20 contains not less than 97.0 percent and not more than 102.0 percent of C53H83NO14 Calculated on the anhydrous, solvent and BHT free basis. Everolimus B20 contains BHT (Butylated hydroxytoluene) 1.75-2.25%.

關聯藥證數量
1

Every disc include antibiotics of Polymyxin B 300u.

關聯藥證數量
1

Evolocumab

關聯藥證數量
1

Exemestane contains not less than 98.0 percent and not more than 102.0 percent of C20H24O2 calculated on the anhydrous basis.

關聯藥證數量
1

Exsiccated Fructus Cardui Mariae extract contains not less than 65.0% of Silymarin, calculated as Silybin.

關聯藥證數量
1

Extract Scoplieae contains total Alkaloid (Hyoscyamine)......0.95-1.15%

關聯藥證數量
1

Extractum Belladonnae JP 0.95-1.15%

關聯藥證數量
1

Ezetimibe 98.0%~102.0% (Calculated on anhydrous and solvent-free basis)

關聯藥證數量
1

Ezetimibe contains 98.0~101.5% of C24H21F2NO3 calculated on dried basis.

關聯藥證數量
1

Ezetimibe Monohydrate (Form B)

關聯藥證數量
1

Ezetimibe contains NLT 98.0 % and NMT 102.0 % of ezetimibe (C24H21F2NO3), calculated on the anhydrous and solvent-free basis.

關聯藥證數量
1

Ezetimibe contains NLT 98.0% and NMT 102.0% of ezetimibe (C24H21F2NO3), calculated on the anhydrous and solvent-free basis.

關聯藥證數量
1

Ezetimibe contains not less than 98.0% and not more than 102.0% of C24H21F2NO3, calculated on anhydrous basis.

關聯藥證數量
1

Ezetimibe contains not less than 98.0% and not more than 102.0% of C24H21F2NO3, calculated on the dried basis.

關聯藥證數量
1

Ezetimibe contains not less than 98.0% and not more than 102.0% of C24H21F2NO3, calculated on the dried substance and solvent-free basis.

關聯藥證數量
1

Ezetimibe contains not less than 98.0% and not more than 102.0% of ezetimibe (C24H21F2NO3), calculated on the anhydrous and solvent-free basis.

關聯藥證數量
1

F. Conjugate Diluent:One bottle, 11 mL, containing a protein-based (BSA) buffer with a non-mercury preservative.G. TMB Chromogen Solution:One bottle, 11 mL, containing a solution of tetramethylbenzidine (TMB) in citrate buffer with hydrogen peroxidase.H. Wash Concentrate:One bottle, 100 mL, containing buffered saline with a nonionic detergent.I. Stopping Solution:One vial, 11 mL, containing 0.2 M sulfuric acid.

關聯藥證數量
1